Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
Abstract NTRK gene fusions are rare somatic mutations found across cancer types with promising targeted therapies emerging. Healthcare systems face significant challenges in integrating these treatments, with uncertainty in prevalence and optimal testing methods to identify eligible patients. We per...
Principais autores: | Sophie O’Haire, Fanny Franchini, Yoon-Jung Kang, Julia Steinberg, Karen Canfell, Jayesh Desai, Stephen Fox, Maarten IJzerman |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Nature Portfolio
2023-03-01
|
coleção: | Scientific Reports |
Acesso em linha: | https://doi.org/10.1038/s41598-023-31055-3 |
Registros relacionados
-
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours
por: Yoon-Jung Kang, et al.
Publicado em: (2022-11-01) -
Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
por: Simon Strohmeier, et al.
Publicado em: (2021-05-01) -
NTRK fusion in Japanese colorectal adenocarcinomas
por: Yuya Yamashiro, et al.
Publicado em: (2021-03-01) -
NTRK1 fusion in glioblastoma multiforme.
por: Jinkuk Kim, et al.
Publicado em: (2014-01-01) -
<i>NTRK</i> Fusions in 1113 Solid Tumors in a Single Institution
por: Heejin Bang, et al.
Publicado em: (2022-06-01)